The WHO suggestions encourage the adoption of those systems, provided they may be validated to reveal equivalent or superior overall performance when compared to classic strategies. Manufacturers trying to apply these procedures will have to present sturdy validation facts to exhibit their equivalence to pharmacopoeial procedures. The WHO